Quick Answer
iSpecimen Inc. reported Operating Income of -$12.73 million for fiscal year 2024.
iSpecimen Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2024 | -$12.73M | -14.0% |
| 2023 | -$11.17M | -9.7% |
| 2022 | -$10.19M | -71.9% |
| 2021 | -$5.93M | -146.2% |
| 2020 | -$2.41M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$2.83M | -66.0% | -55.4% |
| June 30, 2025 | -$1.82M | +16.5% | -11.2% |
| March 31, 2025 | -$1.64M | +45.4% | +3.9% |
| September 30, 2024 | -$1.71M | +22.3% | +21.8% |
| June 30, 2024 | -$2.18M | +38.7% | +27.3% |
| March 31, 2024 | -$3.00M | -18.0% | -36.8% |
| September 30, 2023 | -$2.19M | +29.2% | +38.4% |
| June 30, 2023 | -$3.56M | -37.8% | -40.1% |
- iSpecimen Inc. showed a decrease of -14.0% in Operating Income compared to the prior fiscal year.
- Over the 2020–2024 period, iSpecimen Inc.’s operating income has declined by 428.9% (from -$2.41 million to -$12.73 million).
- The most recent figure is from iSpecimen Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 14, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: